NIH-funded research R01 grant

Improving treatment for spina bifida in unborn babies

Official title: Engineering the fetal environment for in utero treatment of spina bifida bone defect

Funded at University of California at Davis · NIH-11029300 · Data updated 2026-11-12

This study is exploring a new way to help babies with spina bifida by using special cells from the placenta during surgery before they are born, with the goal of repairing their spinal cord and helping their bones grow stronger for better movement later on.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startMarch 24, 2025
Project endJanuary 31, 2030
Funding year2025
Award (this year)$600,475
NIH project number1R01AR085141-01
Project IDNIH-11029300 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are unborn babies diagnosed with myelomeningocele, the most severe form of spina bifida.

Less likely to help

Patients who have already been born with spina bifida or those with other unrelated congenital conditions may not benefit from this research.

What this research studies

This research focuses on enhancing the treatment of spina bifida, a serious birth defect, by using placental stem cells during in utero surgery. The approach aims to not only repair the spinal cord but also regenerate the surrounding bone structure to support long-term motor function. By utilizing the natural regenerative capabilities of the fetal environment, the study seeks to improve outcomes for children affected by this condition. The research will involve advanced bioengineering techniques to create a supportive environment for tissue regeneration.

Why it matters

Potential benefit: If successful, this research could significantly improve mobility and quality of life for children born with spina bifida.

How similar studies have gone: Previous research has shown promise in using stem cells for in utero treatments, but this specific approach to bone regeneration in spina bifida is novel.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Hao, Dake — University of California at Davis
  • Study coordinator: Hao, Dake

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.